These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 35108605)

  • 1. The impact of the overuse of short-acting β2-agonists on the risk of sepsis and septic shock.
    Lai CC; Chen CH; Wang YH; Wang CY; Wang HC
    J Allergy Clin Immunol; 2022 Jul; 150(1):75-81.e1. PubMed ID: 35108605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prevalence and outcome of short-acting β2-agonists overuse in asthma patients in Taiwan.
    Wang CY; Lai CC; Wang YH; Wang HC
    NPJ Prim Care Respir Med; 2021 Apr; 31(1):19. PubMed ID: 33879785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overuse of short-acting β
    Nwaru BI; Ekström M; Hasvold P; Wiklund F; Telg G; Janson C
    Eur Respir J; 2020 Apr; 55(4):. PubMed ID: 31949111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of excessive short-acting β
    Kupczyk M; Barg W; Bochenek G; Brożek G; D Browiecki P; Brzostek D; D Browski A; Dobek R; Gawlik R; Kucharczyk A; Kupryś-Lipińska I; Mastalerz-Migas A; Kowalski ML
    Postepy Dermatol Alergol; 2023 Dec; 40(6):790-797. PubMed ID: 38282873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SABINA: An Overview of Short-Acting β
    Janson C; Menzies-Gow A; Nan C; Nuevo J; Papi A; Quint JK; Quirce S; Vogelmeier CF
    Adv Ther; 2020 Mar; 37(3):1124-1135. PubMed ID: 31981105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SABINA + Hong Kong: a territory wide study of prescribing trends and outcomes associated with the use of short-acting β2 agonists in the Chinese population.
    Fung LW; Yan VK; Kwan C; Kwok WC; Lam DC; McDonald CF; Bloom CI; Wong IC; Chan EW
    BMC Pulm Med; 2024 May; 24(1):232. PubMed ID: 38745268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Over-prescription of short-acting beta agonists in the treatment of asthma.
    Looijmans-van den Akker I; Werkhoven A; Verheij T
    Fam Pract; 2021 Sep; 38(5):612-616. PubMed ID: 33738476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined inhaled anticholinergics and short-acting beta2-agonists for initial treatment of acute asthma in children.
    Griffiths B; Ducharme FM
    Cochrane Database Syst Rev; 2013 Aug; (8):CD000060. PubMed ID: 23966133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Landscape of short-acting beta-agonists (SABA) overuse in Europe.
    de Las Vecillas L; Quirce S
    Clin Exp Allergy; 2023 Feb; 53(2):132-144. PubMed ID: 36468654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic Consequences of the Overuse of Short-Acting ß-Adrenergic Agonists in the Treatment of Asthma in Spain.
    Valero A; Molina J; Nuevo J; Simon S; Capel M; Sicras-Mainar A; Sicras-Navarro A; Plaza V
    J Investig Allergol Clin Immunol; 2023 Apr; 33(2):109-118. PubMed ID: 34825651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of overuse of short-acting beta-2 agonists (SABA) and associated factors among patients with asthma in Germany.
    Worth H; Criée CP; Vogelmeier CF; Kardos P; Becker EM; Kostev K; Mokros I; Schneider A
    Respir Res; 2021 Apr; 22(1):108. PubMed ID: 33863317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usage Patterns of Short-Acting β
    Amin S; Soliman M; McIvor A; Cave A; Cabrera C
    J Allergy Clin Immunol Pract; 2020 Sep; 8(8):2556-2564.e8. PubMed ID: 32244024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is overreliance on short-acting β
    To T; Zhu J; Terebessy E; Zhang K; Gershon AS; Licskai C
    ERJ Open Res; 2022 Jan; 8(1):. PubMed ID: 35350274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Over-prescription of short-acting β
    Khattab A; Madkour A; Ambaram A; Smith C; Muhwa CJ; Mecha JO; Alsayed M; Beekman MJHI
    Curr Med Res Opin; 2022 Nov; 38(11):1983-1995. PubMed ID: 36031882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overprescription of short-acting β
    Al Zaabi A; Busaidi N; Al Mutairy S; Yorgancıoğlu A; Aksu K; Al-Jahdali H; Wali S; Elsayed M; Beekman MJ
    Expert Rev Respir Med; 2022 Jul; 16(7):833-847. PubMed ID: 35848074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-Acting Beta2-Agonist Use in Asthma in Korea: A 10-Year Population-Based Study.
    Lee H; Ryu J; Chung SJ; Yeo Y; Park TS; Park DW; Moon JY; Kim TH; Sohn JW; Yoon HJ; Kim SH
    Allergy Asthma Immunol Res; 2021 Nov; 13(6):945-953. PubMed ID: 34734512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Independent risk factors for death in patients admitted for asthma exacerbation in Taiwan.
    Chang YL; Ko HK; Lu MS; Chou CL; Su KC; Hsu CC; Chou KT; Chen TJ; Perng DW; Chou YC
    NPJ Prim Care Respir Med; 2020 Mar; 30(1):7. PubMed ID: 32193384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Cross-Sectional Study on Prescription Patterns of Short-Acting β
    Pedrozo-Pupo JC; Pacheco Gallego MC; Baños Álvarez IJ; Jaller Raad RA; Caballero Pinilla AC; Reynales Londoño H; Bernal Villada L; Beekman M
    J Asthma Allergy; 2022; 15():1167-1178. PubMed ID: 36051434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Asthma-Related Health Outcomes Associated with Short-Acting β
    Bloom CI; Cabrera C; Arnetorp S; Coulton K; Nan C; van der Valk RJP; Quint JK
    Adv Ther; 2020 Oct; 37(10):4190-4208. PubMed ID: 32720299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real-time asthma outreach reduces excessive short-acting β2-agonist use: a randomized study.
    Zeiger RS; Schatz M; Li Q; Solari PG; Zazzali JL; Chen W
    J Allergy Clin Immunol Pract; 2014; 2(4):445-456, 456.e1-5. PubMed ID: 25017534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.